Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Phillip Berning

10PUBLICATIONS
69CO-AUTHORS
Clinical pharmacology and therapeuticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunologyHaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Jun 09, 2026
Finerenone Prescriptions in the United States (2021-2024) by Physician Specialty: Analysis of Use and Potential in the Cardiovascular-Kidney-Metabolic Space.

|Jun 02, 2026
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis.

|Aug 22, 2025
Immune reconstitution in AML and MDS patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) with treosulfan- or TBI-based conditioning.

Lina Kolloch, Philipp Berning, Jörn C Albring

|Jan 15, 2025
Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia.

Julian Ronnacker, Michael Grau, Maximilian Klasmeier

|Jul 05, 2024
Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years.

Philipp Berning, Mathilde Fekom, Maud Ngoya

|May 03, 2024
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients.

Philipp Berning, Lina Kolloch, Christian Reicherts

Pageof 2

Frequent Collaborators

4 joint publications

Georg Lenz

3 joint publications

Matthias Stelljes

3 joint publications

Christoph Schliemann

2 joint publications

Peter Dreger

2 joint publications

Jörn C Albring

2 joint publications

Lina Kolloch

2 joint publications

Julian Ronnacker

2 joint publications

Michael Grau

2 joint publications

Sarah Sandmann

1 joint publications

Michael Blaha

Frequent Collaborators

4 joint publications

Georg Lenz

3 joint publications

Matthias Stelljes

3 joint publications

Christoph Schliemann

2 joint publications

Peter Dreger